Collaboration with Monogram Biosciences, Inc. , formerly ViroLogic,Inc.,
on development of the new Magtration System
12N, for Nucleic Acid Automated Purification
PSS and Monogram Biosciences, Inc., have been collaborating to develop
an automated nucleic acid purification
system incorporating PSS' Magtration® technology into Monogram Biosciences
HIV PhenoSense® and
GeneSeq® drug resistance process technology. The PSS Magtration® 12N provides custom high
throughput automation for Monogram Biosciences clinical reference laboratory.
Following the delivery of
the first two units of 12N to Monogram Biosciences last fall, the 3rd and
4th 12N have been delivered in June, 2004.
ViroLogic's HIV PhenoSense® and GeneSeq® technology incorporated PSS' Magtration®
technology
and is fully satisfied with quality and throughput.
Magtration System 12N for Nucleic Acid Extraction/Purification

<Reference>
[Monogram Biosciences, Inc.]
Monogram Biosciences is a biotechnology company advancing individualized
medicine by discovering, developing
and marketing innovative products to guide and improve treatment of serious
viral diseases
such as AIDS and hepatitis. The Company's products are designed to help
doctors optimize
treatment regimens that lead to better patient outcomes and reduced costs.
ViroLogic's technology is also being used by numerous biopharmaceutical companies to develop new
and improved anti-viral therapeutics and vaccines targeted at emerging drug-resistant viruses.
More information about the Company and its technology can be found on its
web site
at www.monogrambio.com.